How Does Research in Genomics and Epigenomics Benefit Public Health?
Research in genomics and epigenomics benefits public health by enabling more accurate assessments of how genetic and epigenetic variations influence susceptibility to toxins. This research can inform regulatory decisions, guide interventions to protect vulnerable populations, and lead to the development of novel therapeutic approaches. By understanding the mechanisms underlying toxic responses, we can improve preventive measures and reduce the incidence of toxin-related diseases.
